Will the dark sky over advanced renal cell carcinoma soon become brighter?
- 30 June 2005
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (9) , 1246-1253
- https://doi.org/10.1016/j.ejca.2004.11.025
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Declining mortality from kidney cancer in EuropeAnnals of Oncology, 2004
- Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trialThe Lancet, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Allogeneic Stem-Cell Transplantation of Renal Cell Cancer After Nonmyeloablative Chemotherapy: Feasibility, Engraftment, and Clinical ResultsJournal of Clinical Oncology, 2002
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell CancerJournal of Clinical Oncology, 1999
- Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trialThe Lancet, 1999
- Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.Proceedings of the National Academy of Sciences, 1996
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992